A Mouse Model of Yellow Fever Virus Infection for Study of Pathogenesis and Development of Vaccines and Therapeutics

D. M., Dieye Y, Nguer Cm, Bédékélabou Ap, Boye Csb, Faye O, Fall C
{"title":"A Mouse Model of Yellow Fever Virus Infection for Study of Pathogenesis and Development of Vaccines and Therapeutics","authors":"D. M., Dieye Y, Nguer Cm, Bédékélabou Ap, Boye Csb, Faye O, Fall C","doi":"10.26420/austinjinfectdis.2023.1076","DOIUrl":null,"url":null,"abstract":"Yellow Fever (YF) is a mosquito-borne viral disease that is endemic in several African and South American countries. YF Virus (YFV) causes subclinical infections with mild and non-specific symptoms, to severe, potentially lethal illness. Despite the existence of efficient vaccines, epidemics continue to occur, mostly in Africa. One major drawback of the available YF vaccines is their method of preparation that is fastidious and have limits to produce high volumes of doses needed to respond to recurring epidemics. The best available animal models for YFV are Non-Human Primates (NHP) in which it causes a disease similar to human infection. However, the cost of NHP studies is a limit to preclinical studies. There are a few mouse models of YF. However, these models consist of genetically deficient rodents that are not the best for evaluating new vaccines or therapies. We have developed a mouse model of YFV infection based on the Swiss Webster out bred strain. We have tested several epidemic isolates and identified two strains that, when administrated by the intraperitoneal route, caused an acute infection leading to death. Interestingly, these YFV strains are lethal only when prepared from mouse brain and not when cultured on cell lines. We used this model to test the efficacy of the 17D YFV vaccine strain in protecting mice against lethal challenge showing that the model can be used to evaluate new YF vaccines and therapies.","PeriodicalId":346223,"journal":{"name":"Austin Journal of Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Austin Journal of Infectious Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26420/austinjinfectdis.2023.1076","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Yellow Fever (YF) is a mosquito-borne viral disease that is endemic in several African and South American countries. YF Virus (YFV) causes subclinical infections with mild and non-specific symptoms, to severe, potentially lethal illness. Despite the existence of efficient vaccines, epidemics continue to occur, mostly in Africa. One major drawback of the available YF vaccines is their method of preparation that is fastidious and have limits to produce high volumes of doses needed to respond to recurring epidemics. The best available animal models for YFV are Non-Human Primates (NHP) in which it causes a disease similar to human infection. However, the cost of NHP studies is a limit to preclinical studies. There are a few mouse models of YF. However, these models consist of genetically deficient rodents that are not the best for evaluating new vaccines or therapies. We have developed a mouse model of YFV infection based on the Swiss Webster out bred strain. We have tested several epidemic isolates and identified two strains that, when administrated by the intraperitoneal route, caused an acute infection leading to death. Interestingly, these YFV strains are lethal only when prepared from mouse brain and not when cultured on cell lines. We used this model to test the efficacy of the 17D YFV vaccine strain in protecting mice against lethal challenge showing that the model can be used to evaluate new YF vaccines and therapies.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
黄热病病毒感染小鼠模型的发病机制研究及疫苗和治疗方法的开发
黄热病是一种蚊媒病毒性疾病,在若干非洲和南美洲国家流行。YF病毒(YFV)引起亚临床感染,具有轻微和非特异性症状,严重的,可能致命的疾病。尽管存在有效的疫苗,但流行病继续发生,主要是在非洲。现有的YF疫苗的一个主要缺点是其制备方法过于繁琐,难以生产应对反复出现的流行病所需的大剂量疫苗。可获得的最佳YFV动物模型是非人类灵长类动物(NHP),其引起的疾病与人类感染类似。然而,NHP研究的成本限制了临床前研究。这里有几种YF小鼠模型。然而,这些模型由基因缺陷的啮齿动物组成,并不是评估新疫苗或疗法的最佳方法。我们建立了一种基于瑞士韦伯斯特杂交株的YFV感染小鼠模型。我们已经测试了几种流行分离株,并确定了两种菌株,当通过腹腔注射途径给药时,会引起导致死亡的急性感染。有趣的是,这些YFV菌株只有在从小鼠大脑中制备时才具有致命性,而在细胞系上培养时则没有致命性。我们使用该模型测试了17D YFV疫苗株对小鼠致命攻击的保护作用,表明该模型可用于评估新的YF疫苗和治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Outcome and Risk Factors for Acquisition of Multi-Drug Resistant Organisms among COVID-19 Patients, A Single Center Case Control Study How does the Geocosmos Control the Viruses in Biosphere: DNA, Ionospheric Microwaves and Water A Mouse Model of Yellow Fever Virus Infection for Study of Pathogenesis and Development of Vaccines and Therapeutics The Pathological Changes in Osteoarthritis and Rheumatoid Arthritis Joint Diseases The Role of the NETosis Phenomena as a Function of Neutrophils in the Pathogenesis of Infection and Cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1